TB
Target N V Biotech

Target N V Biotech insider trades: Molecular Templates (MTEM) stock buys and sales

Molecular Templates Last trade Nov 14, 2024 67 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
66
Open-market trades
since 2017
5
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Target reports to the SEC

Open-market buys and sales

66 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 14, 2024MTEM↓ Sell$846K
Apr 2, 2024MTEM↑ Buy$588K
Oct 2, 2023MGNX↑ Buy$670K
Sep 7, 2023MGNX↑ Buy$1.1M
Jul 17, 2023MTEM↑ Buy$2.0M
Feb 14, 2023MGNX↑ Buy$2.5M
Jan 19, 2023MGNX↑ Buy$795K
Dec 27, 2022MGNX↑ Buy$2.3M
Nov 22, 2022MGNX↑ Buy$1.8M
Oct 24, 2022MGNX↑ Buy$2.2M
Oct 20, 2022MGNX↑ Buy$1.8M
May 18, 2022RDUS↑ Buy$2.7M
May 16, 2022MTEM↑ Buy$236K
Jan 6, 2022MTEM↑ Buy$807K
Jan 6, 2022RDUS↑ Buy$3.5M
Nov 19, 2021MGNX↑ Buy$3.7M
Sep 29, 2021RDUS↑ Buy$1.3M
Sep 29, 2021MGNX↑ Buy$4.1M
Sep 22, 2021RDUS↑ Buy$1.8M
Sep 21, 2021MTEM↑ Buy$4.5M
Sep 17, 2021MGNX↑ Buy$12.4M
Sep 16, 2021MTEM↑ Buy$613K
Jul 27, 2021MTEM↑ Buy$1.1M
Jul 20, 2021MTEM↑ Buy$1.7M
Jun 21, 2021MGNX↑ Buy$1.6M
Jun 16, 2021MGNX↑ Buy$3.6M
May 24, 2021ESPR↑ Buy$2.0M
May 19, 2021ESPR↑ Buy$4.1M
May 6, 2021ESPR↑ Buy$4.6M
Apr 19, 2021MTEM↑ Buy$330K
Apr 15, 2021MTEM↑ Buy$1.3M
Apr 14, 2021MTEM↑ Buy$2.0M
Apr 12, 2021MTEM↑ Buy$2.3M
Apr 8, 2021MTEM↑ Buy$4.1M
Apr 5, 2021MTEM↑ Buy$1.9M
Mar 29, 2021MTEM↑ Buy$916K
Feb 24, 2021MTEM↑ Buy$3.5M
Feb 18, 2021MTEM↑ Buy$15.0M
Feb 1, 2021MTEM↑ Buy$935K
Jan 29, 2021MTEM↑ Buy$955K
Dec 10, 2020MTEM↑ Buy$3.7M
Nov 10, 2020MTEM↑ Buy$1.5M
Nov 6, 2020MTEM↑ Buy$4.7M
Nov 5, 2020RDUS↑ Buy$1.4M
Nov 3, 2020ESPR↑ Buy$5.1M
Oct 30, 2020MTEM↑ Buy$1.5M
Sep 14, 2020RDUS↑ Buy$2.3M
Sep 11, 2020RDUS↑ Buy$2.3M
Jul 8, 2020RDUS↑ Buy$330K
Apr 30, 2020RDUS↑ Buy$788K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Target N V Biotech's insider trades

Target N V Biotech is an insider at Molecular Templates (MTEM). Since Nov 15, 2017, Target has reported 65 open-market purchases worth $165.3M and 1 sale worth $846K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MTEM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.